
Hologic, Inc.
NASDAQ:HOLX
60.71 (USD) • At close March 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Hologic, Inc. |
Symbool | HOLX |
Munteenheid | USD |
Prijs | 60.71 |
Beurswaarde | 13,622,716,900 |
Dividendpercentage | 0% |
52-weken bereik | 60.337 - 84.67 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Stephen P. MacMillan |
Website | https://www.hologic.com |
An error occurred while fetching data.
Over Hologic, Inc.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)